The double-blind randomized controlled trial by Salamat S. et al. investigated the effects of multispecies synbiotic supplementation on serum interleukin 10 and fecal short-chain fatty acids (SCFAs) in patients with dyslipidemia. This evidence concerns the gene IL10 and metabolic syndrome.